BUGDF (Bumrungrad Hospital PCL) Growth Rank: 10 (As of Jul. 08, 2026) — 25% Above Median


BUGDF Bumrungrad Hospital PCL BUGDF
100 GF Score
Price $4.75
GF Value $5.35
! 2 Warning Signs
View Full Analysis

What is Bumrungrad Hospital PCL Growth Rank?

Bumrungrad Hospital PCL BUGDF 100 Growth Rank is 10 as of Jul. 08, 2026, which is 25% above its 10-year median of 8.00. GuruFocus rates BUGDF with a GF Score™ of 100/100 and a GF Value™ of $5.35. The stock has 2 warning signs investors should review.

Bumrungrad Hospital PCL has the Growth Rank of 10.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Bumrungrad Hospital PCL Growth Rank Related Terms

BUGDF vs HCA, THC, DVA: Growth Rank Comparison

For the Medical Care Facilities subindustry, Bumrungrad Hospital PCL's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bumrungrad Hospital PCL Growth Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Bumrungrad Hospital PCL's Growth Rank distribution charts can be found below:

* The bar in red indicates where Bumrungrad Hospital PCL's Growth Rank falls into.


BUGDF
100GF Score
Bumrungrad Hospital PCL BUGDF
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 10 mean?
Bumrungrad Hospital PCL (BUGDF) has a Growth Rank of 10 as of Jul. 08, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Bumrungrad Hospital PCL and its competitors. This is 25% above median its historical median of 8.00. Over the past decade, Bumrungrad Hospital PCL's Growth Rank has ranged from 1.00 to 10.00.
Is Bumrungrad Hospital PCL's Growth Rank too high?
Bumrungrad Hospital PCL's current Growth Rank of 10 is 25% above median its 10-year median of 8.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.00. Overall, Bumrungrad Hospital PCL has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.
How does Bumrungrad Hospital PCL's Growth Rank compare to HCA and THC?
Bumrungrad Hospital PCL's Growth Rank of 10 can be compared against companies in the Healthcare Providers & Services industry. Historically, Bumrungrad Hospital PCL's own Growth Rank has ranged from 1.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Healthcare Providers & Services company?
A good Growth Rank depends on the Healthcare Providers & Services industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Bumrungrad Hospital PCL and its competitors. Bumrungrad Hospital PCL's current Growth Rank is 10, which is 25% above median its own 10-year median of 8.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bumrungrad Hospital PCL stock overvalued right now?
Bumrungrad Hospital PCL (BUGDF) has a current Growth Rank of 10. The stock's GF Value™ is $5.35, compared to a current price of $4.75 — trading 11.2% below its estimated fair value. The current Growth Rank is 10, which is 25% above median its 10-year median of 8.00. Bumrungrad Hospital PCL's overall GF Score™ is 100/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Bumrungrad Hospital PCL (BUGDF), the current Growth Rank is 10 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bumrungrad Hospital PCL (BUGDF) Overvalued in 2026?

Based on GuruFocus' analysis, Bumrungrad Hospital PCL stock appears to be undervalued. The current stock price of $4.75 is trading 11.2% below its estimated GF Value™ of $5.35.

Key valuation signals for BUGDF:

  • Growth Rank: 10 (25% above median its 10-year median of 8.00)
  • GF Value™: $5.35 vs. price of $4.75 (11.2% below fair value)
  • GF Score™: 100/100 with 2 warning signs

No single metric tells the full story. See the BUGDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bumrungrad Hospital PCL Business Description

Other Exchanges BH:ThailandBZ7A:Germany
Address 33 Soi 3 (Nana Nua) Sukhumvit Road, Klongtoey Nua Sub District, Wattana District, Bangkok, THA, 10110
Bumrungrad Hospital PCL operates a private hospital business in Bangkok. The company operates several healthcare-related entities, within and outside of Thailand which include Bumrungrad International Hospital, Bumrungrad International Clinic, Vitallife Scientific Wellness Center, VitalLife Skin Clinic, Bumrungrad International Dialysis Clinic, and others. It is a healthcare provider in Thailand providing complete healthcare services for both outpatients and inpatients. The company is the owner and operator of multiple healthcare-related entities. The company has only one main reportable operating segment, which is the hospital and health care center business, and the geographical area of its operations is Thailand.
100GF Score

Get the complete analysis for BUGDF

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.75
Price
$5.35
GF Value